Home Infusion

Full support for infusion – at home.

The Challenge

The infusion market is growing at an annual rate of 15%1; in many cases, these medications are difficult to manage because of complex shipping requirements or specialized administration needs.  Patients must make trips to infusion centers or inpatient facilities to get the treatment they need: approximately 75%2 of infusions take place outside of the home.

  • The home infusion therapy market is expected to grow 64% in the next three years and reach $27B by 20203

  • 34-42% of new specialty drugs in the pipeline are infused4

What is Home Infusion Therapy?

In simple terms, infusion therapy refers to the process in which patients receive medications via needles or catheters in a vein. Receiving this care at home rather than a healthcare facility or other care setting is a more cost-effective option, and is referred to as “home infusion therapy.”

The CareCentrix Approach

CareCentrix provides nursing, drugs, and the administration of supplies and functions to support infusion therapy in the home or Ambulatory Infusion Suite (AIS).

To make this process efficient and effective, CareCentrix:

  • Identifies and recommends to its health plan clients targeted drugs that may be appropriate to transition from higher cost settings to home
  • Optimizes provider networks based on specific drug therapies
  • Collects and monitors provider data to determine how patients are responding to targeted therapy

Benefits

  • Decreased costs

    • Care is directed to the home when possible, rather than higher cost settings
  • Risk reduction

    • A full-support approach to safely manage home infusions
  • Network management

    • Access to more than 1,000 home infusion providers
  • Coordination of infusion services

    • Specialty programs for patients on complex or specialty medications, such as those that treat immune deficiencies or hemophilia

Newsletter Signup

Keep your finger on the pulse of the future of healthcare innovation and sign-up for our monthly newsletter.

Need help managing Home Infusion?

Sources:

  1. National Association of Independent Retail Druggists (NAIRD) in Association with National Home Infusion Association (NHIA)
  2. Shelley, Suzanne. “Home-Infusion Providers Struggle With Unfriendly Reimbursement Policies.” October 2009
  3. Persistence Market Research (PMR), “Home Infusion Therapy Market Will Reach USD 26.7 billion in 2020.” May 2015
  4. http://www.ahdbonline.com/issues/2010/january-february-2010-vol-3-no-1/97-feature-97